Abstract
Each year, 430,000 people are diagnosed with bladder cancer. Due to the high recurrence rate of the disease, primary prevention is paramount (Al-Zalabani et al., Eur J Epidemiol 2016;31(9):811–851, 2016). This chapter covers Mediterranean diet and bladder cancer risk, risk factors in bladder cancer—preventative measures, preventative measures in bladder cancer—impact of vitamin A, prevention of bladder cancer—fluid intake, mitomycin and BCG in bladder cancer prevention, preventative measures and urethral recurrence, BCG in intermediate and high-risk disease.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Al-Zalabani AH, Stewart KF, Wesselius A, Schols AM, Zeegers MP. Modifiable risk factors for the prevention of bladder cancer: a systematic review of meta-analyses. Eur J Epidemiol. 2016;31(9):811–51.
Bravi F, Spei ME, Polesel J, Di Maso M, Montella M, Ferraroni M, Serraino D, Libra M, Negri E, La Vecchia C, Turati F. Mediterranean diet and bladder cancer risk in Italy. Nutrients. 2018;10(8). pii: E1061.
Tang JE, Wang RJ, Zhong H, Yu B, Chen Y. Vitamin A and risk of bladder cancer: a meta-analysis of epidemiological studies. World J Surg Oncol. 2014;12:130.
Michaud DS, Spiegelman D, Clinton SK, Rimm EB, Curhan GC, Willett WC, Giovannucci EL. Fluid intake and the risk of bladder cancer in men. N Engl J Med. 1999;340(18):1390–7.
Mangiarotti B, Trinchieri A, Del Nero A, Montanari E. A randomized prospective study of intravesical prophylaxis in non-muscle invasive bladder cancer at intermediate risk of recurrence: mitomycin chemotherapy vs BCG immunotherapy. Arch Ital Urol Androl. 2008;80(4):167–71.
Chan Y, Fisher P, Tilki D, Evans CP. Urethral recurrence after cystectomy: current preventative measures, diagnosis and management. BJU Int. 2016;117(4):563–9.
Oddens J, Brausi M, Sylvester R, Bono A, van de Beek C, van Andel G, Gontero P, Hoeltl W, Turkeri L, Marreaud S, Collette S, Oosterlinck W. Final results of an EORTC-GU cancers group randomized study of maintenance bacillus Calmette-Guérin in intermediate- and high-risk Ta, T1 papillary carcinoma of the urinary bladder: one-third dose versus full dose and 1 year versus 3 years of maintenance. Eur Urol. 2013;63(3):462–72.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2021 The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Goonewardene, S.S., Ventii, K., Bahl, A., Persad, R., Motiwala, H., Albala, D. (2021). Preventative Measures for Those with High Risk MIBC. In: Management of Muscle Invasive Bladder Cancer. Management of Urology. Springer, Cham. https://doi.org/10.1007/978-3-030-57915-9_21
Download citation
DOI: https://doi.org/10.1007/978-3-030-57915-9_21
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-57914-2
Online ISBN: 978-3-030-57915-9
eBook Packages: MedicineMedicine (R0)